SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jed Davidow who wrote ()2/2/1999 7:55:00 PM
From: JF Quinnelly   of 1728
 
infobeat.com

TABLE - Affymetrix Inc Q4 results

SANTA CLARA, Calif., Feb. 2 (Reuters) -
Affymetrix, Inc.
CONDENSED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended Year Ended
December 31, December 31,
1998 1997 1998 1997
Revenue:
Product $7,906 $2,381 $22,847 $4,789
Contract 5,540 2,647 22,328 7,356
Grant 2,734 2,179 6,850 7,620
Total Revenue 16,180 7,207 52,025 19,765
Costs and expenses:
Cost of product revenue 5,437 1,808 14,858 4,559
Research and development
9,799 8,364 35,953 28,168
Selling, general and
administrative 8,830 5,271 29,763 14,697
Total costs and expenses
24,066 15,443 80,574 47,424
Loss from operations (7,886) (8,236) (28,549) (27,659)
Interest income, net 1,487 1,149 5,419 5,133
Net loss (6,399) (7,087) (23,130) (22,526)
Preferred stock dividends
(813) -- (2,321) --
Loss attributable to
Common stockholders (7,212) (7,087) (25,451) (22,526)
Basic and diluted loss
per common share (0.31) (0.31) (1.11) (0.99)
((Los Angeles Newsroom 213-380-2014))
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext